000 | 01682 a2200481 4500 | ||
---|---|---|---|
005 | 20250513110001.0 | ||
264 | 0 | _c19970124 | |
008 | 199701s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMazzoni, A | |
245 | 0 | 0 |
_aCD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma. _h[electronic resource] |
260 |
_bCancer research _cDec 1996 |
||
300 |
_a5443-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntibodies, Bispecific _ximmunology |
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 | _aAntibody Specificity |
650 | 0 | 4 |
_aCD28 Antigens _ximmunology |
650 | 0 | 4 |
_aCD3 Complex _ximmunology |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _ximmunology |
650 | 0 | 4 |
_aCarrier Proteins _ximmunology |
650 | 0 | 4 | _aCoculture Techniques |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFolate Receptors, GPI-Anchored |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy, Adoptive _xmethods |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 |
_aLymphokines _xmetabolism |
650 | 0 | 4 |
_aNeoplasm Proteins _ximmunology |
650 | 0 | 4 | _aNeoplasm, Residual |
650 | 0 | 4 |
_aOvarian Neoplasms _ximmunology |
650 | 0 | 4 |
_aReceptor-CD3 Complex, Antigen, T-Cell _ximmunology |
650 | 0 | 4 | _aReceptors, Cell Surface |
650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aMezzanzanica, D | |
700 | 1 | _aJung, G | |
700 | 1 | _aWolf, H | |
700 | 1 | _aColnaghi, M I | |
700 | 1 | _aCanevari, S | |
773 | 0 |
_tCancer research _gvol. 56 _gno. 23 _gp. 5443-9 |
|
999 |
_c8959884 _d8959884 |